CS149192A3 - Pharmaceutical composition, process of its preparation and method offungal infections treating - Google Patents

Pharmaceutical composition, process of its preparation and method offungal infections treating

Info

Publication number
CS149192A3
CS149192A3 CS921491A CS149192A CS149192A3 CS 149192 A3 CS149192 A3 CS 149192A3 CS 921491 A CS921491 A CS 921491A CS 149192 A CS149192 A CS 149192A CS 149192 A3 CS149192 A3 CS 149192A3
Authority
CS
Czechoslovakia
Prior art keywords
offungal
infections
treating
preparation
pharmaceutical composition
Prior art date
Application number
CS921491A
Other languages
English (en)
Inventor
Friedrich Dr Richter
Michel Dr Steiger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26298929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CS149192(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919110884A external-priority patent/GB9110884D0/en
Priority claimed from GB919111477A external-priority patent/GB9111477D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CS149192A3 publication Critical patent/CS149192A3/cs
Publication of CZ283019B6 publication Critical patent/CZ283019B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Lubricants (AREA)
CS921491A 1991-05-20 1992-05-18 Topická farmaceutická kompozice, způsob její přípravy a způsob léčení fungálních infekcí CZ283019B6 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919110884A GB9110884D0 (en) 1991-05-20 1991-05-20 Pharmaceutical compositions
GB919111477A GB9111477D0 (en) 1991-05-29 1991-05-29 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
CS149192A3 true CS149192A3 (en) 1992-12-16
CZ283019B6 CZ283019B6 (cs) 1997-12-17

Family

ID=26298929

Country Status (29)

Country Link
US (2) US5681849A (cs)
EP (1) EP0515310B1 (cs)
JP (1) JP2651311B2 (cs)
KR (1) KR100303095B1 (cs)
AT (1) AT400517B (cs)
AU (1) AU647922B2 (cs)
CA (1) CA2068957C (cs)
CH (1) CH683823A5 (cs)
CY (1) CY1942A (cs)
CZ (2) CZ283019B6 (cs)
DE (1) DE4215450B4 (cs)
DK (1) DK0515310T3 (cs)
ES (1) ES2186668T3 (cs)
FI (2) FI981777A0 (cs)
FR (1) FR2676646B1 (cs)
GB (1) GB2255908B (cs)
HK (1) HK148896A (cs)
HU (1) HU223343B1 (cs)
IE (1) IE70913B1 (cs)
IL (1) IL101903A (cs)
IT (1) IT1260710B (cs)
LU (1) LU88114A1 (cs)
MX (1) MX9202328A (cs)
NO (1) NO180772C (cs)
PT (1) PT515310E (cs)
RO (1) RO111986B1 (cs)
SA (1) SA92130087B1 (cs)
SK (1) SK281615B6 (cs)
UA (1) UA39853C2 (cs)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
KR100464601B1 (ko) * 1998-10-23 2004-12-31 이데아 악티엔게젤샤프트 페이로드를 증가시키고, 분리/결합율을 제어하기 위한 거대 분자 결합체 및 복합응집체의 생장, 시험 및 사용방법
EP1031346B1 (en) 1999-01-27 2002-05-02 Idea Ag Noninvasive vaccination through the skin
PT1031347E (pt) 1999-01-27 2002-09-30 Idea Ag Transporte/imunizacao transnasal com veiculos muitissimo adaptaveis
MXPA02000053A (es) * 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
GB0001928D0 (en) * 2000-01-27 2000-03-22 Novartis Ag Organic compounds
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
US7074392B1 (en) 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US8257688B2 (en) * 2000-03-27 2012-09-04 Taro Pharmaceuticals Industries Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
KR100389671B1 (ko) * 2000-11-24 2003-06-27 한미약품 주식회사 염산 테르비나핀을 함유하는 항진균제 외용 약제 조성물
US6490390B1 (en) * 2001-01-05 2002-12-03 Phaethon Communications Grating writing systems based on an acousto-optic element
KR100423666B1 (ko) * 2001-02-07 2004-03-18 보령제약 주식회사 항진균 외용 제제
GB0103046D0 (en) 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
BRPI0101486B1 (pt) * 2001-04-17 2017-09-19 Cristália Produtos Químicos Farmacêuticos Ltda. Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
EP1663142A2 (en) * 2003-06-23 2006-06-07 MacroChem Corporation Compositons and methods for topical administration
WO2005002561A1 (ja) * 2003-07-03 2005-01-13 Taisho Pharmaceutical Co.,Ltd. 外用抗真菌剤組成物
KR100581169B1 (ko) * 2003-07-07 2006-05-17 한국유나이티드제약 주식회사 용해도가 개선된 테르비나핀의 약제조성물 및 그 제조방법
JP2005104916A (ja) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd 抗真菌組成物
KR100978717B1 (ko) 2003-12-08 2010-08-30 씨펙스 파마슈티칼스, 인코포레이티드 인슐린 치료를 위한 약제 조성물 및 방법
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
WO2006003492A2 (en) * 2004-07-02 2006-01-12 Warner-Lambert Company Llc Compositions and methods for treating pathological infections
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
EP1811961A2 (en) * 2004-11-12 2007-08-01 Idea Ag Extended surface aggregates in the treatment of skin conditions
WO2006103638A2 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
CA2615799A1 (en) * 2005-07-21 2007-02-01 Nomir Medical Technologies, Inc. Near infrared microbial elimination laser system (nimels)
US7359057B2 (en) * 2005-08-26 2008-04-15 Ball Aerospace & Technologies Corp. Method and apparatus for measuring small shifts in optical wavelengths
EP1931309B1 (en) 2005-09-29 2012-09-26 Novartis AG Antifungal composition
US20080167312A1 (en) * 2006-12-08 2008-07-10 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted allylamines
JP2010519288A (ja) * 2007-02-21 2010-06-03 パワー ペイパー リミテッド イオン導入法のためのテルビナフィン製剤
WO2008105038A1 (ja) * 2007-02-23 2008-09-04 Nichiban Company Limited 抗真菌症用貼付剤
WO2008121709A1 (en) * 2007-03-30 2008-10-09 Transport Pharmaceuticals, Inc. Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug
US20090082469A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched terbinafine
BRPI0921685A2 (pt) * 2008-10-31 2016-02-16 Moberg Derma Ab composição tópica compreendendo uma combinação de pelo menos dois agentes que melhoram a penetração.
ES2598753T3 (es) 2012-11-27 2017-01-30 Eduardo Cos Alfonso Composición farmacéutica para el tratamiento de la tendinitis calcificada y/o bursitis calcificada
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EP3226972A4 (en) 2014-12-01 2018-08-08 Achelios Therapeutics, Inc. Methods and compositions for treating migraine and conditions associated with pain
GB201511799D0 (en) * 2015-07-06 2015-08-19 Blueberry Therapeutics Ltd Composition and methods of treatment
US20180369174A1 (en) * 2015-12-16 2018-12-27 Achelios Therapeutics, Inc. Methods and compositions for treating peripheral neuropathy
TWI656883B (zh) * 2017-08-21 2019-04-21 高雄醫學大學 光敏劑或其前驅藥物的醫藥載體
KR20250024938A (ko) * 2022-05-20 2025-02-20 덤바이온트, 인코포레이티드 피부 질환, 병태 및 장애의 예방, 치료 및 개선을 위한 pk 억제제의 사용을 위한 조성물 및 제제

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
DE2716943C2 (de) * 1976-04-28 1986-08-14 Sandoz-Patent-GmbH, 7850 Lörrach N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
CY1410A (en) * 1979-08-22 1988-04-22 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
FR2572933B1 (fr) * 1981-04-06 1988-03-18 Sandoz Sa Compositions pharmaceutiques topiques a base de tizanidine
JPS6058914A (ja) * 1983-09-12 1985-04-05 Shionogi & Co Ltd イミダゾ−ル系抗真菌性外用ゲル製剤
US4912124A (en) * 1984-02-23 1990-03-27 Ortho Pharmaceutical Corporation Antifungal dermatological solution
JPS61151117A (ja) * 1984-12-25 1986-07-09 Bayer Yakuhin Kk 抗真菌ゲル製剤
US4760096A (en) * 1985-09-27 1988-07-26 Schering Corporation Moisturizing skin preparation
JP2633555B2 (ja) * 1987-03-23 1997-07-23 株式会社東芝 半導体装置の製造方法
ES2038344T3 (es) * 1988-01-13 1993-07-16 Schwarz Pharma Ag Soluciones concentradas de corticoesteroides y metodo para su fabricacion.
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
US5116603A (en) * 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
HUT58201A (en) * 1989-03-03 1992-02-28 Sandoz Ag Process for producing antiphlogistic pharmaceutical composition containing naphtalene-methan-amino derivatives
FR2646603B1 (fr) * 1989-05-03 1991-07-12 Oreal Composition nettoyante
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
FR2666962B1 (fr) * 1990-09-26 1996-06-14 Oreal Composition antifongique sous forme de spray sec.
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására

Also Published As

Publication number Publication date
GB2255908A (en) 1992-11-25
IL101903A0 (en) 1992-12-30
IL101903A (en) 1998-08-16
ITRM920361A0 (it) 1992-05-12
SA92130087B1 (ar) 2006-05-23
ATA102392A (de) 1995-06-15
MX9202328A (es) 1994-04-29
KR920021139A (ko) 1992-12-18
UA39853C2 (uk) 2001-07-16
KR100303095B1 (ko) 2001-11-22
AU647922B2 (en) 1994-03-31
NO921958D0 (no) 1992-05-18
US5856355A (en) 1999-01-05
ITRM920361A1 (it) 1993-11-12
RO111986B1 (ro) 1997-04-30
HU9201518D0 (en) 1992-07-28
GB2255908B (en) 1995-10-04
PT515310E (pt) 2003-03-31
FI922252A0 (fi) 1992-05-18
FI102458B1 (fi) 1998-12-15
FI922252L (fi) 1992-11-21
FR2676646B1 (fr) 1995-05-05
CH683823A5 (de) 1994-05-31
LU88114A1 (fr) 1993-12-06
GB9210579D0 (en) 1992-07-01
CA2068957C (en) 2002-12-17
FI981777L (fi) 1998-08-18
US5681849A (en) 1997-10-28
IT1260710B (it) 1996-04-22
NO180772B (no) 1997-03-10
JPH05132419A (ja) 1993-05-28
DK0515310T3 (da) 2003-03-03
CY1942A (en) 1997-05-16
CZ285275B6 (cs) 1999-06-16
FI981777A7 (fi) 1998-08-18
AT400517B (de) 1996-01-25
HUT62466A (en) 1993-05-28
IE921599A1 (en) 1992-12-02
DE4215450B4 (de) 2006-04-27
IE70913B1 (en) 1997-01-15
NO180772C (no) 1997-06-18
AU1631792A (en) 1992-11-26
SK281615B6 (sk) 2001-05-10
NO921958L (no) 1992-11-23
EP0515310B1 (en) 2002-11-06
FI981777A0 (fi) 1998-08-18
ES2186668T3 (es) 2003-05-16
DE4215450A1 (de) 1992-11-26
FI102458B (fi) 1998-12-15
JP2651311B2 (ja) 1997-09-10
EP0515310A1 (en) 1992-11-25
CZ283019B6 (cs) 1997-12-17
FR2676646A1 (fr) 1992-11-27
CA2068957A1 (en) 1992-11-21
HK148896A (en) 1996-08-16
HU223343B1 (hu) 2004-06-28

Similar Documents

Publication Publication Date Title
TJ270B (en) 5,6-Dichlorobenzimidazole derivatives process for their preparation pharmaceutical composition and method of treatment or prophylaxis of virus infections
CS153292A3 (en) Pharmaceutical preparation, process for preparing thereof, and method ofonychomycosis treating
ZA896864B (en) Method and composition for the treatment and prevention of viral infections
CZ56595A3 (en) Substituted thiazolidinedione derivatives, process of their preparation, pharmaceutical preparation in which they are comprised and their use
CS257491A3 (en) 3-amidopyrazole derivatives, process of their preparation and pharmaceutical compositions comprising them
CS189391A3 (en) Dialkoxypiridylbenzimidazole derivatives, process of their preparation and their pharmaceutical use
AU2187992A (en) Composition and method for disease treatment
PL300335A1 (en) Pharmaceutical agent, novel derivatives of 4-thiazinylinone and method of obtaining such novel derivatives
FI923548A7 (fi) Vaahtoa muodostava koostumus farmaseuttiseen käyttöön, sen käyttö ja h oitomenetelmä
CS20091A2 (en) Basic calciumaluminiumhydroxidedicarboxylate, method of its preparation and its application
AU5287090A (en) Method and composition for treatment of periodontal disease
CZ129596A3 (en) Oxazolidinone derivative, process of its preparation and pharmaceutical composition containing thereof
HU9402832D0 (en) Imidazol-4-yl-piperidine derivatives, process for producing them and pharmaceutical use of them
HU9303171D0 (en) Pharmaceutical compositions for preventing and treating tumouric illnesses and process for preparing them
SK60895A3 (en) Taxane derivatives and process for their preparation
CS331491A3 (en) Cyclopeptides, process of their preparation and pharmaceuticals based thereon
CS299991A3 (en) Derivatives of 2-aminopyrimidine-4-carboxamide, process of their preparation and their application as medicaments
CZ346595A3 (en) Substituted derivatives of 4-phenylthiazoles, process of their preparation and pharmaceutical compositions containing thereof
CZ92295A3 (en) Boronpeptide derivatives, process of their preparation and pharmaceutical composition containing thereof
CS265391A3 (en) Novel thienodiazepines, process for their preparation and pharmaceutical comprising them
AU6796287A (en) Method and composition for prophylaxis and treatment of viral infections
CS235091A3 (en) Novel derivatives of 1-diphenylmethylpiperazine, process of their preparation and their application as medicaments
HU9303376D0 (en) Process for producing alpha, omega-diaryl-alkane derivatives and pharmaceutical compositions containing them
GR3034886T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them
HUT57051A (en) Pharmaceutical composition for treating tonsilitis and process for producing them

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MK4A Patent expired

Effective date: 20120518